BergasaN.V., JonesE.A.The pruritus of cholestasis. Semin Liver Dis1993; 13: 319–27.
2.
DattaD.V., SherlockS.Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology1966; 50: 323–32.
3.
GhentC.N., CarruthersS.G.Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial. Gastroenterology1988; 94: 488–93.
4.
BergasaN.V., AllingD.W., TalbotT.L.Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial. Ann Intern Med1995; 123: 161–7.
5.
WolfhagenF.H., SternieriE., HopW.C., VitaleG., BertolottiM., Van BuurenH.R.Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology1997; 113: 1264–9.
6.
LauterburgB.H., TaswellH.F., PinedaA.A., DicksonE.R., BurgstalerE.A., CarlsonG.L.Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet1980; ii: 53–5.
7.
MitznerS.R., StangeJ., KlammtS., PeszynskiP., SchmidtR.Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin Nephrol Hypertens2001; 10: 777–3.
8.
MüllhauptB., Kullak-UblickG.A., AmbühlP.M., StockerR., RennerE.L.Successful use of the molecular adsorbent recirculating system (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus. Hepatol Res2003; 25: 442–6.
9.
BellmannR., GraziadeiI.W., FeistritzerC., SchwaighoferH., StellaardF., SturmE., WiedermannC.J., JoannidisM.Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl2004; 10: 107–14.
10.
MaciaM., AvilesJ., NavarroJ., MoralesS., GarciaJ.Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med2003; 114: 62–4.
11.
DoriaC., MandalaL., SmithJ.Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transpl2003; 9: 437–43.
12.
SturmE., FranssenC.F., GouwA.Extracorporeal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver2002; 22(suppl 2): S72–5.
13.
BeuersU., SpenglerU., ZwiebelF.M., PauletzkiJ., FischerS., PaumgartnerG.Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology1992; 15: 603–8.
